Regulation of Thyroid Hormone Receptor Isoforms in Physiological and Pathological Cardiac Hypertrophy

Circulation Research - United States
doi 10.1161/hh1901.096706
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Differential and Conditional Activation of PKC-Isoforms Dictates Cardiac Adaptation During Physiological to Pathological Hypertrophy

PLoS ONE
Multidisciplinary
2014English

Differential Role of G Protein-Coupled Receptor Kinase 5 in Physiological Versus Pathological Cardiac Hypertrophy

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2015English

Fibronectin Contributes to Pathological Cardiac Hypertrophy but Not Physiological Growth

Basic Research in Cardiology
Cardiovascular MedicinePhysiologyCardiology
2013English

Mechanisms for the Transition From Physiological to Pathological Cardiac Hypertrophy

Canadian Journal of Physiology and Pharmacology
MedicinePhysiologyPharmacology
2020English

Impaired Repressor Function in SUMOylation-Defective Thyroid Hormone Receptor Isoforms

European Thyroid Journal
EndocrinologyMetabolismDiabetes
2016English

Structural Basis of GC-1 Selectivity for Thyroid Hormone Receptor Isoforms

BMC Structural Biology
Structural Biology
2008English

Role of Interferon Regulatory Factor 4 in the Regulation of Pathological Cardiac Hypertrophy

Hypertension
Internal Medicine
2013English

Differential Expression of Thyroid Hormone Receptor Isoforms Is Strikingly Related to Cardiac and Skeletal Muscle Phenotype During Postnatal Development

Journal of Molecular Endocrinology
EndocrinologyMolecular Biology
1999English

Characterization of the Contribution of Retinoic Acid Receptor Isoforms in the Suppression of Cardiac Hypertrophy

Biophysical Journal
Biophysics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy